Quality Control of a Strengthening Protocol in Subjects With Spinal Cord Injury (MKraft_Erstr)

January 9, 2020 updated by: Swiss Paraplegic Centre Nottwil

Quality Control of an In-hospital Strengthening Protocol in Spinal Cord Injured Subjects During Initial Rehabilitation - a Prospective Observational Study

The aim of the master's thesis is to evaluate the clinic-internal strengthening concept of the Swiss Paraplegic Centre (SPZ). The SPZ is a rehabilitation clinic for spinal cord injured people. The strengthening concept has been routinely used since 2015.

By default, the patients complete - depending on which training phase they are in - three to four strength training sessions per week. As part of the master's thesis, the development of maximum strength of patients with spinal cord injury (SCI) in primary rehabilitation will be studied. It is explicitly taken care of that the patients comply with the training requirements. Furthermore, factors which prevent a consistent buildup of strength - such as medical complications (pressure sores, pneumonia, urinary tract infections) - are systematically recorded.

The findings should provide information on the effect and qualitative transfer of the existing strength concept in everyday clinical practice. The strength training performed is accompanied by the master student and documented in a standardized manner.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lucerne
      • Nottwil, Lucerne, Switzerland, 6207
        • Swiss Paraplegic Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Subjects with acute spinal cord injury during their initial rehabilitation

Description

Inclusion Criteria:

  • Patients in initial rehabilitation
  • SCI Level C1-C5 (ASIA Score C-D)
  • SCI Lever C6-L5 (ASIA Score A-D)
  • Traumatic and non-traumatic SCI
  • Disease-related paraplegia, high-grade stenoses and central cord Syndromes
  • Age >= 18 years
  • The maximum force is tested on three predefined training devices, two devices for the upper and a device for the lower extremity. The participants will only be included in the study if they are capable of succeeding in at least both exercises for the upper extremity

Exclusion criteria:

  • Polyneuropathic diseases such as Critical Illness and Guillain Barré Syndrome
  • Degenerative diseases such as multiple sclerosis and amyotrophic lateral sclerosis etc.
  • Cognitive impairments
  • Compliance of less than 2/3 of the training sessions
  • ≥ 14 days without training
  • more than 6 weeks between assessments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
SCI patients in primary rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
One-repetition-maximum as parameter for the maximum force [kg]
Time Frame: Change from 0 weeks to 5 weeks and from 5 weeks to 10 weeks
Calculated one-repetition-maximum based on the Brzycki equation formula
Change from 0 weeks to 5 weeks and from 5 weeks to 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of completed training sessions (training compliance)
Time Frame: Change from 0 weeks to 5 weeks and from 5 weeks to 10 weeks
Number of completed training sessions per participant
Change from 0 weeks to 5 weeks and from 5 weeks to 10 weeks
Causes of study exclusion
Time Frame: From 0 weeks to 10 weeks
Systematic documentation of exclusion causes during the participation in the study
From 0 weeks to 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2018

Primary Completion (Actual)

June 30, 2019

Study Completion (Actual)

November 30, 2019

Study Registration Dates

First Submitted

October 11, 2018

First Submitted That Met QC Criteria

October 11, 2018

First Posted (Actual)

October 16, 2018

Study Record Updates

Last Update Posted (Actual)

January 13, 2020

Last Update Submitted That Met QC Criteria

January 9, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injury, Acute

3
Subscribe